Feeding and metabolism in mice lacking pituitary adenylate cyclase-activating polypeptide

Endocrinology

Volumn 149, Issue 4, 2008, Pages 1571-1580

  Adams, Bruce A ^a,b   Gray, Sarah L ^c,e   Isaac, Emma R ^a   Bianco, Antonio C ^d   Vidal Puig, Antonio J ^c   Sherwood, Nancy M ^a  

^a UNIVERSITY OF VICTORIA   (Canada)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e UNIVERSITY OF NORTHERN BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; INSULIN; MESSENGER RNA; NEUROPEPTIDE; PROTIRELIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BROWN ADIPOSE TISSUE; CONTROLLED STUDY; ENERGY EXPENDITURE; ENZYME METABOLISM; FAT INTAKE; FEEDING; FEMALE; FOOD INTAKE; GENE DISRUPTION; GENETIC CONSERVATION; HYPOTHALAMUS; INSULIN SENSITIVITY; LOCOMOTION; MALE; METABOLIC RATE; METABOLIC REGULATION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REGULATORY MECHANISM; THERMOREGULATION; THYROID HORMONE BLOOD LEVEL; WILD TYPE;

ADIPOGENESIS; ANIMALS; BODY TEMPERATURE REGULATION; COLD; EATING; ENERGY METABOLISM; INSULIN; MICE; MICE, INBRED C57BL; MUSCLE, SKELETAL; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; THYROID HORMONES; THYROTROPIN-RELEASING HORMONE;

EID: 41549130871     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2007-0515     Document Type: Article

References (44)

1. Miyata A, Arimura A, Dahl RR, Minamino N, Uehara A, Jiang L, Culler MD, Coy DH 1989 Isolation of a novel 38-residue hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochem Biophys Res Commun 164:567-574
2. Miyata A, Jiang L, Dahl RD, Kitada C, Kubo K, Fujino M, Minamino N, Arimura A 1990 Isolation of a neuropeptide corresponding to the N-terminal 27 residues of the pituitary adenylate cyclase activating polypeptide with 38 residues (PACAP38). Biochem Biophys Res Commun 170:643-648
3. Harmar AJ, Arimura A, Gozes I, Journot L, Laburthe M, Pisegna JR, Rawlings SR, Robberecht P, Said SI, Sreedharan SP, Wank SA, Waschek JA 1998 International Union of Pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide. Pharmacol Rev 50:265-270
4. Laburthe M, Couvineau A, Nicole P 2003 Molecular pharmacology and structure-function analysis of PACAP/VIP receptors. In: Vaudry H, Arimura A, eds. Pituitary adenylate cyclase-activating polypeptide. New York, NY: Kluwer Academic Publishers; 69-93
5. Filipsson K, Kvist-Reimer M, Ahren B 2001 The neuropeptide pituitary adenylate cyclase-activating polypeptide and islet function. Diabetes 50:1959-1969
6. Hamelink C, Tjurmina O, Damadzic R, Young WS, Weihe E, Lee HW, Eiden LE 2002 Pituitary adenylate cyclase-activating polypeptide is a sympathoadrenal neurotransmitter involved in catecholamine regulation and glucohomeostasis. Proc Natl Acad Sci USA 99:461-466
7. Nussdorfer GG, Malendowicz LK 1998 Role of VIP, PACAP, and related peptides in the regulation of the hypothalamo-pituitary-adrenal axis. Peptides 19:1443-1467
8. Murakami Y, Koshimura K, Yamauchi K, Nishiki M, Tanaka J, Kato Y 2001 Roles and mechanisms of action of pituitary adenylate cyclase-activating polypeptide (PACAP) in growth hormone and prolactin secretion. Endocr J 48:123-132
9. Absood A, Chen D, Wang ZY, Hakanson R 1992 Vascular effects of pituitary adenylate cyclase activating peptide: a comparison with vasoactive intestinal peptide. Regul Peptides 40:323-329
10. Freson K, Hashimoto H, Thys C, Wittevrongel C, Danloy S, Morita Y, Shintani N, Tomiyama Y, Vermylen J, Hoylaerts MF, Baba A, Van Geet C 2004 The pituitary adenylate cyclase-activating polypeptide is a physiological inhibitor of platelet activation. J Clin Invest 113:905-912
11. Mercer A, Ronnholm H, Holmberg J, Lundh H, Heidrich J, Zachrisson O, Ossoinak A, Frisen J, Patrone C 2004 PACAP promotes neural stem cell proliferation in adult mouse brain. J Neurosci Res 76:205-215
12. Nishimoto M, Furuta A, Aoki S, Kudo Y, Miyakawa H, Wada K 2007 PACAP/PAC1 autocrine system promotes proliferation and astrogenesis in neural progenitor cells. Glia 55:317-327
13. Sherwood NM, Gray SL, Cummings KJ 2003 Consequences of PACAP gene knockout. In: Vaudry H, Arimura A, eds. Pituitary adenylate cyclase-activating polypeptide. New York, NY: Kluwer Academic Publishers; 347-360
14. Hashimoto H, Shntani N, Tanaka K, Mori W, Irose M, Matsuda T, Sakaue M, Miyazaki J, Niwa H, Tashiro F, Yamamoto K, Koga K, Tomimoto S, Kunugi A, Suetake S, Baba A 2001 Altered psychomotor behaviors in mice lacking pituitary adenylate cyclase-activating polypeptide (PACAP). Proc Natl Acad Sci USA 98:13355-13360
15. Otto C, Martin M, Wolfer DP, Kipp HP, Maldonado R, Schutz G 2001 Altered emotional behavior in PACAP-type-I-receptor-deficient mice. Mol Brain Res 92:78-84
16. Gray SL, Cummings KJ, Jirik FR, Sherwood NM 2001 Targeted disruption of the pituitary adenylate cyclase-activating polypeptide gene results in early postnatal death associated with dysfunction of lipid and carbohydrate metabolism. Mol Endocrinol 15:1739-1747
17. Zigman JM, Elmquist JK 2003 From anorexia to obesity: the yin and yang of body weight control. Endocrinology 144:3749-3756
18. Brabet P, Jamen F, Rodriguez-Henche N, Bertrand G, Bockaert J 2003 PACAP receptor knockout and transgenics: What have we learnt? In: Vaudry H, Arimura A, eds. Pituitary adenylate cyclase-activating polypeptide. NewYork, NY: Kluwer Academic Publishers; 321-346
19. Gray SL, Yamaguchi N, Vencová P, Sherwood NM 2002 Temperature-sensitive phenotype in mice lacking pituitary adenylate cyclase-activating polypeptide. Endocrinology 143:3946-3954
20. Yada T, Sakurada M, Filipsson K, Kikuchi M, Ahren B 2000 Intraperitoneal PACAP administration decreases blood glucose in GK rats, and in normal and high fat diet mice. Ann NY Acad Sci 921:259-263
21. Yada T, Nakata M, Shioda S 2000 Insulinotropin PACAP potentiates insulin action. Stimulation of glucose uptake in 3T3-LI adipocytes. Ann NY Acad Sci 921:473-477
22. Gu HF 2002 Genetic variation screening and association studies of the adenylate cyclase activating polypeptide 1 (ADCYAP1) gene in patients with type 2 diabetes. Hum Mutat 19:572-573
23. Segal JP, Stallings NR, Lee CE, Zhao L, Socci N, Viale A, Harris TM, Soares MB, Childs G, Elmquist JK, Parker KL, Friedman JM 2005 Use of laser-capture microdissection for the identification of marker genes for the ventromedial hypothalamic nucleus. J Neurosci 25:4181-4188
24. Morley JE, Horowitz M, Morley PM, Flood JF 1992 Pituitary adenylate cyclase activating polypeptide (PACAP) reduces food intake in mice. Peptides 13: 1133-1135
25. Chance WT, Thompson H, Thomas I, Fischer JE 1995 Anorectic and neurochemical effects of pituitary adenylate cyclase activating polypeptide in rats. Peptides 16:1511-1516
26. Mizuno Y, Kondo K, Terashima Y, Arima H, Murase T, Oiso Y 1998 Anorectic effect of pituitary adenylate cyclase activating polypeptide (PACAP) in rats: lack of evidence for involvement of hypothalamic neuropeptide gene expression. J Neuroendocrinol 10:611-616
27. Tachibana T, Tomonaga S, Oikawa D, Saito S, Takagi T, Saito ES, Boswell T, Furuse M 2003 Pituitary adenylate cyclase activating polypeptide and vasoactive intestinal peptide inhibit feeding in the chick brain by different mechanisms. Neurosci Lett 348:25-28
28. Tachibana T, Saito S, Tomonaga S, Takagi T, Saito ES, Boswell T, Furuse M 2003 Intracerebroventricular injection of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibits feeding in chicks. Neurosci Lett 339:203-206
29. Matsuda K, Maruyama K, Nakamachi T, Miura T, Shioda S 2006 Effects of pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide on food intake and locomotor activity in the goldfish, Carassius auratus. Ann NY Acad Sci 1070:417-421
30. Tachibana T, Saito ES, Takahashi H, Saito S, Tomonaga S, Boswell T, Furuse M2004 Anorexigenic effects of pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal peptide in the chick brain are mediated by corticotrophin-releasing factor. Regul Peptides 120:99-105
31. Christoffolete MA, Ribeiro R, Singru P, Fekete C, da Silva WS, Gordon DF, Huang SA, Crescenzi A, Harney JW, Ridgway EC, Larsen PR, Lechan RM, Bianco AC 2006 Atypical expression of type 2 iodothyronine deiodinase in thyrotrophs explains the thyroxine-mediated pituitary thyrotropin feedback mechanism. Endocrinology 147:1735-1743
32. Matsuno R, Ohtaki H, Nakamachi T, Watanabe J, Yofu S, Hayashi D, Takeda T, Nonaka N, Seki M, Nakamura M, Itabashi K, Shioda S 2007 Distribution and localization of pituitary adenylate cyclase-activating polypeptide-specific receptor (PAC1R) in the rostral migratory stream of the infant mouse brain. Regul Peptides 145:80-87
33. Fekete C, Lechan RM 2007 Negative feedback regulation of hypophysiotropic thyrotropin-releasing hormone (TRH) synthesizing neurons: role of neuronal afferents and type 2 deiodinase. Front Neuroendocrinol 28:97-114
34. Nakata M, Kohno D, Shintani N, Nemoto Y, Hashimoto H, Baba A, Yada T 2004 PACAP deficient mice display reduced carbohydrate intake and PACAP activates NPY-containing neurons in the rat hypothalamic arcuate nucleus. Neurosci Lett 370:252-256
35. Bachman ES, Dhillon H, Zhang C-Y, Cinti S, Bianco AC, Kobilka BK, Lowell BB 2002 βAR signaling required for diet-induced thermogenesis and obesity resistance. Science 297:843-845
36. -/- mice. J Biol Chem 281:31894-31908
37. Ukropec J, Anunciado RV, Ravussin Y, Kozak LP 2006 Leptin is required for uncoupling protein-1-independent thermogenesis during cold stress. Endocrinology 147:2468-2480
38. Legradi G, Hannibal J, Lechan RM 1997 Association between pituitary adenylate cyclase-activating polypeptide and thyrotropin-releasing hormone in the rat hypothalamus. J Chem Neuroanat 13:265-279
39. Das M, Vihlen CS, Legradi G 2007 Hypothalamic and brainstem sources of pituitary adenylate cyclase-activating polypeptide nerve fibers innervating the hypothalamic paraventricular nucleus in the rat. J Comp Neurol 500:761-776
40. Coppola A, Liu Z-W, Andrews ZB, Paradis E, Roy M-C, Friedman JM, Ricquier D, Richard D, Horvath TL, Gao XB, Diano S 2007 A central thermogenic-like mechanism in feeding regulation: an interplay between arcuate nucleus T3 and UCP2. Cell Metab 5:21-33
41. Crantz FR, Silva JE, Larsen PR 1982 An analysis of the sources and quantity of 3,5,3′-triiodothyronine specifically bound to nuclear receptors in rat cerebral cortex and cerebellum. Endocrinology 110:367-375
42. Asnicar MA, Koster A, Heiman ML, Tinsley F, Smith DP, Galbreath E, Fox N, Ma YL, Blum WF, Hsiung HM 2002 Vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating peptide receptor 2 deficiency in mice results in growth retardation and increased basal metabolic rate. Endocrinology 143:3994-4006
43. Persson K, Ahren B 2002 The neuropeptide PACAP contributes to the glucagon response to insulin-induced hypoglycaemia in mice. Acta Physiol Scand 175:25-28
44. Jamen F, Persson K, Bertrand G, Rodriguez-Henche N, Puech R, Bockaert J, Ahren B, Brabet P 2000 PAC1 receptor-deficient mice display impaired insulinotropic response to glucose and reduced glucose tolerance. J Clin Invest 105:1307-1315